Hickerson Comments on U.S. Trade Relations with China
April 11, 2019
World Intellectual Property Review
Partner David Hickerson was quoted in a World Intellectual Property Review article, “Trade relations: Sending in the big guns,” about whether the Trump administration is overreaching the scope of its trade tools in its fight against Chinese bad actors.
Hickerson said he believes the administration is using the March 2018 U.S. Trade Representative’s section 301 report into “China’s Acts and Policies on IP, Technology Transfer and Innovation,” to exert influence in trade negotiations. “If Trump imposes tariffs on all Chinese imports, as has been threatened, this will be an overreach of section 301,” he said.
Hickerson also said the International Trade Commission has used section 337 cases over the past two decades to target Chinese companies. “The number of cases filed against Chinese respondents exceeds the number of ITC filings against respondents from all other countries (excluding the U.S.) combined,” he added.
Hickerson said he believes the administration is using the March 2018 U.S. Trade Representative’s section 301 report into “China’s Acts and Policies on IP, Technology Transfer and Innovation,” to exert influence in trade negotiations. “If Trump imposes tariffs on all Chinese imports, as has been threatened, this will be an overreach of section 301,” he said.
Hickerson also said the International Trade Commission has used section 337 cases over the past two decades to target Chinese companies. “The number of cases filed against Chinese respondents exceeds the number of ITC filings against respondents from all other countries (excluding the U.S.) combined,” he added.
People
Related News
June 10, 2025
In the News
James McFall Joins Iconic Athletes and Leaders in Launch of Stanford Football Alumni United
Foley & Lardner LLP is proud to announce that partner James Carlos McFall is a founding member of Stanford Football Alumni United (SFAU), a newly formed coalition of former players and leaders committed to supporting Stanford Football’s continued growth and national competitiveness.
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."
June 6, 2025
In the News
Louis Lehot Comments on Crypto Company IPO – 'Definitely a home run'
Foley & Lardner LLP partner Louis Lehot commented on the initial public offering of stablecoin issuer Circle in the Law360 article, "Circle's Smash IPO Could Pave Way For More Crypto Listings."